Erythromycin-13C2

• Description:

  Erythromycin-13C2 is a macrolide antibiotic that can be used to treat respiratory infections, skin infections, and chlamydia infections[1].

• UNSPSC:

  12352005

• Target:

  Bacterial

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/erythromycin-13c2.html

• Purity:

  95.0

• Solubility:

  10 mM in DMSO

• Smiles:

  C[C@@H]([C@@H]([C@H](C(O[C@@H]([C@@](O)([C@@H]([C@H](C([C@@H](C[C@]1(O)C)C)=O)C)O)C)CC)=O)C)O[C@H]2C[C@](C)([C@H]([C@@H](O2)C)O)OC)[C@H]1O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N([13CH3])[13CH3])O

• Molecular Formula:

  C35 13C2H67NO13

• Molecular Weight:

  735.91

• References & Citations:

  [1]Brittain DC. Erythromycin. Med Clin North Am. 1987 Nov;71 (6) :1147-54. doi: 10.1016/s0025-7125 (16) 30802-1.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Isotope-Labeled Compounds

• Clinical Information:

  No Development Reported

• CAS Number:

  [202114-52-1]